Beyond Air Inc
NASDAQ:XAIR
Beyond Air Inc
NASDAQ:XAIR
Price:
1.05
USD
-3.67%
Market Closed
Market Cap:
$4.3m
Relative Value
There is not enough data to reliably calculate the relative value of XAIR.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
XAIR
Relative Value
Base Case
Not Available
Multiples Across Competitors
XAIR Competitors Multiples
Beyond Air Inc Competitors
Beyond Air Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Beyond Air Inc
NASDAQ:XAIR
|
4.2m USD | 0.7 | -0.1 | -0.1 | -0.1 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
189.6B USD | 4.3 | 29.1 | 16.5 | 22.5 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
171B USD | 17 | 59.8 | 45.5 | 55.1 | |
| US |
|
Stryker Corp
NYSE:SYK
|
138.8B USD | 5.5 | 42.9 | 21.7 | 26.3 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
132.5B USD | 3.8 | 27.8 | 15.6 | 22.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
115.7B USD | 6 | 41.5 | 24.6 | 33.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
58.8B USD | 2.7 | 35.1 | 12.8 | 21.9 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
45.7B EUR | 2 | 21.5 | 12.2 | 17.2 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51.8B USD | 12 | 48.7 | 34.8 | 38.4 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
45.4B USD | 7.7 | 33.2 | 23.6 | 25.8 | |
| US |
|
Resmed Inc
NYSE:RMD
|
39B USD | 7.2 | 26.2 | 18.5 | 20.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
